Preprint
Article

This version is not peer-reviewed.

Chemical-Protein and Protein-Protein Interaction Network of Vanillin from Clove: Functional and Pathway Analysis in Homo sapiens

Submitted:

22 March 2025

Posted:

27 March 2025

You are already at the latest version

Abstract
Clove is an ancient spice with powerful medicinal characteristics that may treat a wide range of diseases while also controlling beneficial effects on the body. Its bioactive component, vanillin (4-hydroxy-3-methoxybenzaldehyde), has a beneficial effect on human health. This study aims to identify proteins that interact with vanillin in order to predict their possible impacts on the human body. We retrieved 99 protein sequences from the STITCH, STRING, UniProtKB, and NCBI databases and interacted with them, resulting in 49 sequences after the BLAST search. A functional annotation research revealed both positive and negative regulatory mechanisms important for the maintenance of biological processes, molecular activities, and cellular components in human health. Pathway analysis indicated that these compounds play significant roles in KEGG and Reactome-related pathways.Furthermore, the vanillin molecule possesses anticancer, antioxidant, antisickling, antimicrobial, and anti-inflammatory activities that suppress a variety of genetic diseases, neurological diseases, and cancers. Consequently, this research will aid in the identification of therapeutic-related protein interactions and signaling pathways, as well as the development of medications containing vanillin.
Keywords: 
;  ;  ;  

1. Introduction

A medium-sized tree (8–12 m) belonging to the Myrtaceae family, Syzygium aromaticum (synonym: Eugenia cariophylata) is a common phenolic plant, spice, and more specifically essential oils (EOs), which have a high content of bioactive compounds and are commonly known as clove(Cortés-Rojas, de Souza, et al., 2014). It is native to the Maluku Islands in east Indonesia and can be grown across the world, including Brazil in the state of Bahia, Madagascar (Ullah & Hamza, 2023). One of the most precious spices, cloves have been used for centuries as a food preservation agent, for therapeutic use, and as an essential oil (EO) in the food, cosmetics, pharmaceutical, biomedical, and sanitary sectors(Cav, Roda Rita, Amaury Taboada Rodriguez, 2021). One of the most efficient sources of phenolic compounds, comprising eugenol, vanillin, gallic acid, eugenol acetate, β-caryophyllene, and several others, contains cloves.
Vanillin (4-hydroxy-3-the methoxybenzaldehyde) is the most widespread phenolic compound isolated from cloves(Kamat et al., 2000). It has substantial antimutagenic and anticarcinogenic capabilities that alleviate the proliferation of malignancies in the colon that are triggered by multiple agents in rat models. Many researchers have been investigating vanillin's antimutagenic qualities during the past few decades(Akagi et al., 1995; Imanishi et al., 1990). Vanillin's antimutagenic role in mutagenesis generated by 4-nitroquinoline 1-oxide, furylfuramide, captan, or methylglyoxal in Escherichia coli was initially demonstrated back in 1986 (Tai et al., 2011). A diet containing considerable amounts of vanillin, which has anticancer and antioxidant properties, may lessen the development of cancer via free radicals (Tai et al., 2011). Human health will be adversely affected by high quantities of vanillin consumed from meals and beverages(Tai et al., 2011). Both in vitro and in vivo, vanillin was said to be lowering X-ray or UV light-induced mutations in mammalian cells(Imanishi et al., 1990). Reactive oxygen species (ROS) scavenging, error-prone SOS repair inhibition, non-homologous DNA end-joining inhibition, and recA-dependent recombinational repair-enhancing protein have all been proposed as reasons for vanillin's antimutagenic properties(K. L. Ho et al., 2009). In order to cure sickle cell anemia (HBS), vanillin boasts anti-sickling properties(Arya et al., 2021). High-performance liquid chromatography was used to find that vanillin covalently comprises sickle hemoglobin (HBS) in red blood cell solutions(Abraham et al., 1991).Vanillin facilitated insulin glycation and amyloid aggregation for causing neurodegenerative disease and nephropathy, neuropathy, and retinopathy diabetes, and additionally it demonstrated cytoprotective and antioxidant actions against Advanced Glycation End Products (AGE) and Non-Enzymatic Glycation (NEG)(Awasthi & Saraswathi, 2016). Vanillin reveals neuroprotective properties in animals, including ischemia and Huntington's disease (HD)(Gupta & Sharma, 2014a). It also has a substantial impact on learning memory and locomotory motor coordination in rats with 3-nitropropionic acid (3NPA)-induced HD(Gupta & Sharma, 2014a). Vanillin shows natural wound healing features, and its chitosan hydrogel based on Schiff base and hydrogen connection between them, and additionally the chitosan-vanillin membrane, have been shown recently for promoting angiogenic stimulation, collagen deposition, and re-epithelialization in tissue engineering(Xu et al., 2018). Vanillin has applications in the cosmeceutical industry due to its aroma and antioxidant features, which have played an important part in skin renewal and healing processes(Taboonpong et al., 2017). Vanillin blocked the production of pro-inflammatory cytokines and UV-B-induced phosphorylation of ataxia telangiectasia mutants (ATM), serine-threonine kinase checkpoint kinase 2 (Chk2), tumor suppressor protein 53 (p53), and p38/mitogen-activated protein kinase (p38), leading to therapeutic benefits and antioxidant effects(Lee et al., 2014).
Bioinformatics has historically given important tools for evaluating these types of investigations. The Biochemical Interactions Indexing Engine and the Protein Interactions Database Search Engine have notable manuals on chemical-protein and protein-protein interaction systems, making it straightforward to figure out the adverse effects of Vanillin. STITCH is a web-based service that analyzes the interactions between chemicals and proteins inside particular organisms via testing and methodical scraping (Kuhn et al., 2014). STRING 12.0 is a web server for conserving and organizing protein-protein interactions, particularly biological and physical(Szklarczyk et al., 2023). Furthermore, Omicsbox has been utilized for analyzing genomic and proteomic data, discovering correlations between genetic sequences in biological functions, molecular activities, and cellular components, and identifying pathways utilizing resources such as KEGG and Reactome. Understanding whether human proteins interact with the naturally occurring substance vanillin, as well as showcasing the biological, cellular, and molecular functions of all of these proteins and the beneficial and adverse consequences of vanillin, are among the intended objectives of this study.

2. Methods and Materials

2.1. Network Retrieval

In the current study, Vanillin interacts with human (Homo sapiens) proteins compiled from the STITCH 5.0 (http://stitch.embl.de) internet server, as described by Ali et al. Vanillin attaches to human proteins and is then utilized for detecting protein-protein interactions. Use STRING to get all known human protein linkages from both direct (physical) and indirect (functional) sources.

2.2. Sequencing Assortment

Protein-protein interactions have been highlighted in the table, which was used to generate protein sequences by utilizing the FASTA and UniProt (https://www.uniprot.org/) databases. During the sequence collecting procedure, redundant sequences were discarded and all acquired protein sequences have been assembled in a single FASTA file for additional analysis.format retrieved from the NCBI protein database (https://www.ncbi.nlm.nih.gov/protein/).

2.3. Functional and Pathway Analysis

OmicsBox 3.2 is bioinformatics software used to evaluate NGS data from genomes, transcriptomes, and metagenomes. OmicsBox software has been employed to execute biological annotation and pathway investigation on FASTA protein sequences.

3. Results

3.1. Interaction Prediction

In the current research on both the beneficial and detrimental effects of clove vanillin on Homo sapiens have been explored using STITCH 5.0, a bioinformatics analysis tool that provides a possible network of 9 proteins (Figure 1). The function and interaction scores is illustrated in Table 1.
Using the bioinformatics tools STRING 12.0, it was determined that each of the 9 proteins for Vanillin interacted with another 10 proteins, yielding a total of 99 proteins for Vanillin. Each protein's interaction network was graphically depicted (Figure 2), and their unique protein-protein interactions (PPI) were reported in Table 2.

3.2. Protein Accession, Amino Acid Sequence Retrieval

Using STRING 12.0 for the PPI analysis, we identified 99 proteins from Vanillin. These proteins' accession numbers and amino acid lengths were compiled concurrently from the protein databases UniProtKB and NCBI. We used protein-protein blast to minimize duplication and gathered FASTA files for functional annotation analysis using these protein accession codes. Following a blast analysis in Table 3, we identified 49 proteins and conducted functional annotation.

3.3. Functional Annotation Analysis and Pathway Analysis after Blast Search

In the current research, functional annotation evaluation of vanillin reveals very effective biological processes, cellular components, and molecular activities in humans (Figure 3). Pathway analysis of vanillin was additionally identified using omics box tools, and the analysis indicates many sorts of signaling pathways in various species with their correct IDs and different kinds of databases, such as KEGG (Kyoto Encyclopedia of Genes and Genomes) and Reactome, as shown in Table 4.
Vanillin regulates anatomical structure development, lipid metabolism, transmembrane transport, inflammatory response, signaling and carbohydrate metabolism, transferase activity, transporter activity, lipid-binding molecular function, and regulatory activity (Figure 3). The analysis of pathways also reveals several types of signaling pathways, including the P53 signaling pathway, JAK-STAT pathway, relaxin signaling pathway, mTOR signaling pathway, PPAR signaling pathway, IL-17 signaling pathway, MAPK pathway, thyroid hormone signaling pathway, cAMP signaling pathway, and Hippo pathway. The pathway assessment depicts a variety of diseases, most notably coronavirus disease (COVID-19), tuberculosis, hepatitis B, hepatitis C, diabetic cardiomyopathy, malaria, and Cushing syndrome; it is also responsible for several types of cancer, including microRNA cancer, proteoglycan cancer, prostate cancer, bladder cancer, and transcriptional misregulation.
Vanillin and its related proteins are often found in cellular components, including the endoplasmic reticulum, extracellular space, cytosol, plasma membrane, and mitochondria (Figure 3). These proteins additionally serve a crucial function in many different types of metabolism, particularly ascorbate and aldarate metabolism, selenocompound metabolism, vitamin D metabolism, cysteine and methionine metabolism, retinol metabolism, tryptophan metabolism, glycine, serine metabolism, arachidonic acid metabolism, linoleic metabolism, nitrogen metabolism, porphyrine metabolism, drug metabolism, and the ingestion of SetMet, Sec, and Msec into H2Se met (Table 4).

4. Discussion

Clove (Syzygium aromaticum) is a spice plant with chemotherapeutical properties, including vanillin, which has constructive impacts on the human physique (Cortés-Rojas, De Souza, et al., 2014). Vanillin is observed in numerous species and has bioenergetic interactions. It is a flavor and aromatic compound and modulates metabolic and signaling pathways .
Bioinformatics research makes it easier to find a wide range of proteins and their activities, as well as functionally annotate and analyze these proteins. These kinds of proteins have been linked to a variety of illnesses, including metabolic, neurological, and genetic disorders, as well as several forms of cancer. Vanillin is absorbed via many modes of exposure and eliminated in the urine, with a tiny amount excreted as unmetabolized vanillin (K. Ho et al., 2011).
Vanillin was found to interact with 49 functional proteins that are linked to human health. Vanillin has anti-inflammatory, antibacterial, antibiotic potential, antifungal, and antiviral properties, among other things (Vanillin: A Review on the Therapeutic Prospects of a Popular Flavouring Molecule | Advances in Traditional Medicine, n.d.) (Antibacterial Mechanism of Vanillin against Escherichia Coli O157: H7: Heliyon, n.d.) (Vanilla Modulates the Activity of Antibiotics and Inhibits Efflux Pumps in Drug-Resistant Pseudomonas Aeruginosa | Biologia, n.d.) (Full Article: Antifungal Activity of Vanilla Juice and Vanillin against Alternaria Alternata, n.d.) . Vanillin was additionally shown to have anticlastogenic, antimutagenic, and anticancer effects, making it a potential nutraceutical molecule (Mourtzinos et al., 2009).According to the study that we conducted, vanillin acts on the cell cycle, causes apoptosis, and prevents cancer. Ho et al. found that the compound inhibited G2/M and G0/G1 cell cycle stages in 5-bromo-2-deoxyuridine-labeling cell proliferation and caused apoptosis in HT-29 cancer cells (IC50 value of 400 μg/ml), indicating potential for colorectal cancer prevention (K. Ho et al., 2009).
Vanillin's anti-inflammatory and antioxidant qualities aid in the treatment of hypoxic-ischemic brain damage and Alzheimer's disease(Albrecht et al., 2019) (Iannuzzi et al., 2023). It's a neurodevelopmental and neurodegenerative condition. It occurs as a result of a shortage of oxygen and a restriction of blood flow in the brain, triggering anaerobic metabolism (Albrecht et al., 2019). Vanillin's antioxidant properties, the hippo signaling pathway, and other interleukin signaling pathways all contribute to the prevention of some types of deficits. According to Lan and colleagues' research on the rat model, vanillin plays a critical part during these diseases; hippo signaling pathways and interleukin pathways help to prevent those diseases because vanillin promotes early neurofunction development, mitigates histo-morphological damage, and protects neuronal damage in the cortex and hippocampal CA1 and CA3 regions after HIBD in neonatal rats (Lan et al., 2019).
Vanillin modulates a wide range of metabolic activities and signaling pathways in the human body. This molecule has an effect on cell signaling, differentiation, anatomical structure creation, programmed cell death, the inflammatory response, glucose and lipid metabolism, nerve control, and other processes. Furthermore, these bioactive compounds have a direct relationship with the cell's subcellular organelles. Vanillin has been seen to interact with cell membranes, nucleoplasm, endoplasmic reticulum, cytosol, mitochondria, and the extracellular space. According to Gupta and Sharma's rat model experiments, vanillin ameliorated 3-nitropropionic acid-induced defective mitochondrial enzyme complexes (I, II, and IV) and prevented Huntington's disease (Gupta & Sharma, 2014b). Vanillin also protects the mitochondria, and its protective mechanism assists to activate the antiapoptotic pathway via the mitochondria(Neurosupportive Role of Vanillin, a Natural Phenolic Compound, on Rotenone Induced Neurotoxicity in SH-SY5Y Neuroblastoma Cells - Dhanalakshmi - 2015 - Evidence-Based Complementary and Alternative Medicine - Wiley Online Library, n.d.) . Moreover, Sheetal D Ullal and Yogesh Belagali demonstrated that vanillin serves a key part in lipid metabolism, and that when co-administered with HFD, vanillin can lower total cholesterol, triglyceride, and VLDL-C levels compared to the HFD control and atorvastatin groups, as well as contribute to reducing those parameters via free radical scavenging activity (Belagali et al., 2013).
Vanillin and its derivatives have medicinal qualities that treat a number of human ailments. Amor et al. (2014) found that vanillin works on a variety of neurodegenerative diseases, including Parkinson's disease, traumatic brain and spinal cord injury, stroke, multiple sclerosis, neuropsychiatric disorders, and amyotrophic lateral sclerosis, as well as neuropsychiatric disorders and genetic disorders caused by progressive neuron dysfunction in the central nervous system (Amor et al., 2014). Industrially manufactured vanillin is utilized as a flavoring ingredient in a wide range of goods, including fragrances. It is a source of dopa, leading to the precursors of the neurotransmitters dopamine, norepinephrine, and epinephrine (Martău et al., 2021). Vanillin is projected to play a major part in pharmaceuticals and biomedicine due to its derivatives activity, which employs different chemicals for diverse reasons and develops innovative composites that are employed in a variety of illnesses, disorders, and other applications. Many chemicals have already been successfully tested, including metal particles, metal oxides, nanoparticles, phenolic compounds, plant extracts, biopolymers, pharmaceuticals, and so on. Even if the synthesized compounds are low in toxicity and biocompatible, the possibilities for combinations are endless (Kafali et al., 2024). Our study solely looked at the potential adverse outcomes of vanillin; we need molecular drug design and animal experiments to determine the advantageous and detrimental impacts of these compounds.

5. Conclusions

Our findings show that several proteins interact with vanillin and have potential therapeutic effects (biological, molecular, and cellular), as well as other types of pathway activity that are directly or indirectly influenced by the human body. This bioinformatics technique precisely identified various possible activities and pathways (apoptosis, hippo signaling pathways, interleukin pathway) that mitigate cancer, inflammation, and neurodegenerative illness. Apoptosis is a critical function that regulates the cell cycle and prevents colorectal cancer; hippo signaling pathways protect neurons and prevent hypoxic-ischemic brain damage. Notably, these medications are utilized to treat a wide range of illnesses. Vanillin inhibits infectious diseases such as malaria, hepatitis B, and hepatitis C. However, another research revealed that vanillin is widely used in the pharmaceutical business due to its antibacterial properties and wound healing activity. The limitation of this study is that it needs to declare those proteins, and additionally, in vitro and in vivo studies are needed to illustrate the rest. The downside of this investigation involves the fact that it must reveal those proteins, and more in vitro and in vivo investigations are required to demonstrate the rest.

References

  1. Abraham, D. J., Mehanna, A. S., Wireko, F. C., Whitney, J., Thomas, R. P., & Orringer, E. P. (1991). Vanillin, a potential agent for the treatment of sickle cell anemia. Blood, 77(6), 1334–1341. [CrossRef]
  2. Akagi, K., Hirose, M., Hoshiya, T., Mizoguchi, Y., Ito, N., & Shirai, T. (1995). Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Letters, 94(1), 113–121. [CrossRef]
  3. Albrecht, M., Zitta, K., Groenendaal, F., van Bel, F., & Peeters-Scholte, C. (2019). Neuroprotective strategies following perinatal hypoxia-ischemia: Taking aim at NOS. Free Radical Biology and Medicine, 142, 123–131. [CrossRef]
  4. Amor, S., Peferoen, L. A. N., Vogel, D. Y. S., Breur, M., Van Der Valk, P., Baker, D., & Van Noort, J. M. (2014). Inflammation in neurodegenerative diseases – an update. Immunology, 142(2), 151–166. [CrossRef]
  5. Antibacterial mechanism of vanillin against Escherichia coli O157: H7: Heliyon. (n.d.). Retrieved December 13, 2024, from https://www.cell.com/heliyon/fulltext/S2405-8440(23)06488-5.
  6. Arya, S. S., Rookes, J. E., Cahill, D. M., & Lenka, S. K. (2021). Vanillin: A review on the therapeutic prospects of a popular flavouring molecule. Advances in Traditional Medicine, 21(3), 415–431. [CrossRef]
  7. Awasthi, S., & Saraswathi, N. T. (2016). Vanillin restrains non-enzymatic glycation and aggregation of albumin by chemical chaperone like function. International Journal of Biological Macromolecules, 87, 1–6. [CrossRef]
  8. Belagali, Y., Ullal, S. D., Shoeb, A., Bhagwath, V., Ramya, K., & Maskeri, R. (2013). Effect of Vanillin on lipid profile in a model of hyperlipidemia, a preliminary study. IJEB Vol.51(04) [April 2013]. http://nopr.niscpr.res.in/handle/123456789/16551.
  9. Cav, Roda Rita, Amaury Taboada Rodriguez, et al. (2021). Synergistic Antimicrobial Activities of Combinations of.
  10. Cortés-Rojas, D. F., de Souza, C. R. F., & Oliveira, W. P. (2014). Clove (Syzygium aromaticum): A precious spice. Asian Pacific Journal of Tropical Biomedicine, 4(2), 90–96. [CrossRef]
  11. Cortés-Rojas, D. F., De Souza, C. R. F., & Oliveira, W. P. (2014). Clove (Syzygium aromaticum): A precious spice. Asian Pacific Journal of Tropical Biomedicine, 4(2), 90–96. [CrossRef]
  12. Full article: Antifungal activity of vanilla juice and vanillin against Alternaria alternata. (n.d.). Retrieved December 13, 2024, from https://www.tandfonline.com/doi/full/10.1080/19476337.2019.1586776.
  13. Gupta, S., & Sharma, B. (2014a). Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington’s disease. Pharmacology Biochemistry and Behavior, 122, 122–135. [CrossRef]
  14. Gupta, S., & Sharma, B. (2014b). Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington’s disease. Pharmacology Biochemistry and Behavior, 122, 122–135. [CrossRef]
  15. Ho, K. L., Yazan, L. S., Ismail, N., & Ismail, M. (2009). Apoptosis and cell cycle arrest of human colorectal cancer cell line HT-29 induced by vanillin. Cancer Epidemiology, 33(2), 155–160. [CrossRef]
  16. Ho, K., Yazan, L. S., Ismail, N., & Ismail, M. (2009). Apoptosis and cell cycle arrest of human colorectal cancer cell line HT-29 induced by vanillin. Cancer Epidemiology, 33(2), 155–160. [CrossRef]
  17. Ho, K., Yazan, L. S., Ismail, N., & Ismail, M. (2011). Toxicology study of vanillin on rats via oral and intra-peritoneal administration. Food and Chemical Toxicology, 49(1), 25–30. [CrossRef]
  18. Iannuzzi, C., Liccardo, M., & Sirangelo, I. (2023). Overview of the Role of Vanillin in Neurodegenerative Diseases and Neuropathophysiological Conditions. International Journal of Molecular Sciences, 24(3), 1817. [CrossRef]
  19. Imanishi, H., Sasaki, Y. F., Matsumoto, K., Watanabe, M., Ohta, T., Shirasu, Y., & Tutikawa, K. (1990). Suppression of 6-TG-resistant mutations in V79 cells and recessive spot formations in mice by vanillin. Mutation Research Letters, 243(2), 151–158. [CrossRef]
  20. Kafali, M., Finos, M. A., & Tsoupras, A. (2024). Vanillin and Its Derivatives: A Critical Review of Their Anti-Inflammatory, Anti-Infective, Wound-Healing, Neuroprotective, and Anti-Cancer Health-Promoting Benefits. Nutraceuticals, 4(4), 522–561. [CrossRef]
  21. Kamat, J. P., Ghosh, A., & Devasagayam, T. P. A. (2000). [No title found]. Molecular and Cellular Biochemistry, 209(1/2), 47–53. [CrossRef]
  22. Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T. H., Von Mering, C., Jensen, L. J., & Bork, P. (2014). STITCH 4: Integration of protein–chemical interactions with user data. Nucleic Acids Research, 42(D1), D401–D407. [CrossRef]
  23. Lan, X.-B., Wang, Q., Yang, J.-M., Ma, L., Zhang, W.-J., Zheng, P., Sun, T., Niu, J.-G., Liu, N., & Yu, J.-Q. (2019). Neuroprotective effect of Vanillin on hypoxic-ischemic brain damage in neonatal rats. Biomedicine & Pharmacotherapy, 118, 109196. [CrossRef]
  24. Lee, J., Cho, J. Y., Lee, S. Y., Lee, K.-W., Lee, J., & Song, J.-Y. (2014). Vanillin protects human keratinocyte stem cells against Ultraviolet B irradiation. Food and Chemical Toxicology, 63, 30–37. [CrossRef]
  25. Mourtzinos, I., Konteles, S., Kalogeropoulos, N., & Karathanos, V. T. (2009). Thermal oxidation of vanillin affects its antioxidant and antimicrobial properties. Food Chemistry, 114(3), 791–797. [CrossRef]
  26. Neurosupportive Role of Vanillin, a Natural Phenolic Compound, on Rotenone Induced Neurotoxicity in SH-SY5Y Neuroblastoma Cells—Dhanalakshmi—2015—Evidence-Based Complementary and Alternative Medicine—Wiley Online Library. (n.d.). Retrieved December 13, 2024, from https://onlinelibrary.wiley.com/doi/full/10.1155/2015/626028.
  27. Szklarczyk, D., Kirsch, R., Koutrouli, M., Nastou, K., Mehryary, F., Hachilif, R., Gable, A. L., Fang, T., Doncheva, N. T., Pyysalo, S., Bork, P., Jensen, L. J., & Von Mering, C. (2023). The STRING database in 2023: Protein–protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Research, 51(D1), D638–D646. [CrossRef]
  28. Taboonpong, S., Kiratipaiboon, C., Phiboonchaiyanan, P. P., Junthongjin, P., Trithossadech, P., & Chanvorachote, P. (2017). Vanillin increases stem cell signal and cell adhesion in keratinocytes. Thai Journal of Pharmaceutical Sciences (TJPS), 41(2), Article 2. http://www.tjps.pharm.chula.ac.th/ojs/index.php/tjps/article/view/368.
  29. Tai, A., Sawano, T., Yazama, F., & Ito, H. (2011). Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays. Biochimica et Biophysica Acta - General Subjects, 1810(2), 170–177. [CrossRef]
  30. Ullah, M. A., & Hamza, A. H. A. (2023). Role of Clove in Human Medical History. SAR Journal of Anatomy and Physiology, 4(02), 10–19. [CrossRef]
  31. Vanilla modulates the activity of antibiotics and inhibits efflux pumps in drug-resistant Pseudomonas aeruginosa | Biologia. (n.d.). Retrieved December 13, 2024, from https://link.springer.com/article/10.2478/s11756-020-00617-5.
  32. Vanillin: A review on the therapeutic prospects of a popular flavouring molecule | Advances in Traditional Medicine. (n.d.). Retrieved December 13, 2024, from https://link.springer.com/article/10.1007/S13596-020-00531-W.
  33. Xu, C., Zhan, W., Tang, X., Mo, F., Fu, L., & Lin, B. (2018). Self-healing chitosan/vanillin hydrogels based on Schiff-base bond/hydrogen bond hybrid linkages. Polymer Testing, 66, 155–163. [CrossRef]
Figure 1. Using STITCH 5.0, interactions between vanillin and human proteins are predicted.
Figure 1. Using STITCH 5.0, interactions between vanillin and human proteins are predicted.
Preprints 153220 g001
Figure 2. Protein-Protein interaction (PPI) of Vanillin identified via STRING 12.0.
Figure 2. Protein-Protein interaction (PPI) of Vanillin identified via STRING 12.0.
Preprints 153220 g002
Figure 3. Functional annotation analysis of Vanillin showed the various biological processes (a), localization of cellular components (b) and molecular functions (c) of different proteins in Homo sapiens.
Figure 3. Functional annotation analysis of Vanillin showed the various biological processes (a), localization of cellular components (b) and molecular functions (c) of different proteins in Homo sapiens.
Preprints 153220 g003
Table 1. List of proteins that interact with Vanillin identified using STITCH 5.0, along with their short descriptions.
Table 1. List of proteins that interact with Vanillin identified using STITCH 5.0, along with their short descriptions.
PROTEIN CODE ACCESSION NUMBER INFORMATION SCORE AMINO ACID
CA1 ENSP00000430656 carbonic anhydrase I; 0.700 261
CA2 ENSP00000285379 carbonic anhydrase II; 0.700 260
UGT1A7 ENSP00000362525 UDP glucuronosyltransferase 1 family, polypeptide A7 0.737 530
UGT1A3 ENSP00000418532 UDP glucuronosyltransferase 1 family, polypeptide A7; 0.737 534
UGT1A10 ENSP00000343838 UDP glucuronosyltransferase 1 family, polypeptide A7; 0.739 530
UGT1A8 ENSP00000362549 UDP glucuronosyltransferase 1 family, polypeptide A7; 0.739 530
KCNK3 ENSP00000306275 potassium channel, subfamily K, member 3; 0.800 394
MMP9 ENSP00000361405 matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase); 0.800 707
TRPV3 ENSP00000461518 transient receptor potential cation channel, subfamily V, member 3 0.818 790
Table 2. The interaction between vanillin and proteins has been identified using the STITCH and STRING technologies.
Table 2. The interaction between vanillin and proteins has been identified using the STITCH and STRING technologies.
Stitch CA1 CA2 UGT1A7 UGT1A3 UGTA10 UGT1A8 KCNK3 MMP9 TRPV3
String AHSP CA1 UGT1A6 UGT1A9 UGT1A1 UGT1A6 KCNK9 TIMP1 TRPM8
ALAS2 ATP6V1B1 UGT1A1 UGT1A6 UGT1A8 UGT1A9 S100A100 TIMP2 HIF1AN
HBD CBS UGT1A10 UGT1A1 UGT1A6 UGT1A3 KRT76 LCN2 ANK1
CA2 CBSL UGT1A9 UGT1A8 UGT1A9 UGT1A1 KCNK5 CD44 ANK3
EPB42 TCIRG1 UGT1A4 UGT1A4 UGT1A4 UGT1A10 KCNK18 THBS1 ANK2
SLC4A1 SLC9A1 UGT1A8 UGT1A10 UGT1A7 UGT1A4 KCNK1 TIMP3 TRPM3
GYPB SLC4A4 UGT1A3 UGT1A7 UGT1A3 UGT1A7 KCNK10 CTSG TRPM4
SELENBP1 SLC4A1 CYP3A4 CYP3A4 CYP3A4 CYP3A4 YWHAB DMP1 TRPA1
STAT4 CYP24A1 SLC35A2 CYP2D6 SLC35A2 SLC35A2 SCN10A ELN TRPC5
CYP24A1 CLCN7 CYP1A1 SLC35A2 CYP1A1 CYP1A1 ANXA2 MMP1 TRPM7
Table 3. List of vanillin interacting proteins of STRING 12.0 after blast searching.
Table 3. List of vanillin interacting proteins of STRING 12.0 after blast searching.
SL
No
Accession Number Protein name Amino acid SL
No
Accession Number Protein name Amino acid SL
No
Accession Number Protein name Amino acid
1 AAH27890.1 CA1 261 18 NP_659505.1 790 35 NP_002091.4 GYPB 91
2 CAG38763.1 CA2 260 19 NP_001305151.1 AHSP 102 36 CAG33133.1 SELENBP1 472
3 AAG30419.1 UGT1A7 530 20 NP_000023.2 ALAS2 587 37 NP_003142.1 STAT4 748
4 NP_061966.1 UDP1A3 534 21 NP_000510.1 HBD 147 38 NP_000773.2 CYP24A1 514
5 AAG30417.1 UGT1A10 530 22 AAH96094.1 EPB42 691 39 NP_066307.1 UGT1A9 530
6 NP_061949.3 UGT1A8 530 23 NP_061948.1 UGT1A10 530 40 NP_059488.2 CYP3A4 503
7 NP_002237.1 KCNK3 394 24 NP_009051.1 UGT1A3 534 41 NP_001306146.1 CD44 742
8 NP_004985.2 MMP9 707 25 NP_005651.1 SLC35A2 396 42 NP_000353.1 TIMP3 211
9 NP_001683.2 ATP6V1B1 513 26 NP_003237.2 THBS1 1170 43 NP_056932.2 KRT76 638
10 AAH10242.1 CBS 551 27 NP_001902.1 CTSG 255 44 NP_003731.1 KCNK5 499
11 XP_054180901.1 CBSL 551 28 NP_004398.1 DMP1 513 45 NP_862823.1 KCNK18 384
12 NP_006010.2 TCIRG1 830 29 NP_001265868.1 ELN 786 46 NP_002236.1 KCNK1 336
13 NP_003038.2 SLC9A1 815 30 NP_002412.1 MMP1 469 47 NP_612190.1 KCNK10 543
14 NP_001091954.1 SLC4A4 1079 31 NP_001269463.1 KCNK9 374 48 NP_003395.1 YWHAB 246
15 NP_001278.1 CLCN7 805 32 NP_002957.1 S100A10 97 49 AAH93056.1 ANXA2 339
16 NP_001063.2 UGT1A6 532 33 NP_006505.4 SCN10A 1956
17 NP_000454.1 UGT1A1 533 34 NP_000333.1 SLC4A1 911
Table 4. KEGG and Reactome Pathways analysis of Vanillin interacted Proteins.
Table 4. KEGG and Reactome Pathways analysis of Vanillin interacted Proteins.
KEGG ID PATHWAY KEGG ID PATHWAY KEGG ID PATHWAY
Ko04510 Focal adhesion Ko05200 Pathways in cancer Ko04360 Axon guidance
Ko00941 Flavonoid biosynthesis Ko04350 TGF beta signaling pathway Ko05171 Coronavirus disease-COVID19
Ko04115 P53 signaling pathway Ko05160 Hepatitis C Ko04080 Neuroactive ligand receptor interaction
Ko05204 Chemical carcinogenesis,DNA adducts Ko05161 Hepatitis B Ko00040 Pentose and glucuronate interconversions
Ko05322 Systemic lupus erythematosus Ko04929 GnRH secretion Ko05165 Human papillomavirus infection
Ko04750 Inflammatory mediator regulation of TRP channels Ko04927 Cortisol synthesis and secretion Ko00270 Cysteine and methionine metabolism
Ko05169 Epstein barr virus infection Ko04928 Parathyroid hormone synthesis,secretion and action Ko00791 Atrazine degradation
Ko05323 Rheumatoid arthritis Ko04925 Aldosterone synthesis and secretion Ko04624 Toll and Imd signaling pathway
Ko04630 JAK-STAT pathway Ko00053 Ascorbate and aldarate metabilism Ko00830 Retinol metabolism
Ko05202 Transcriptional misregulation in cancer Ko04926 Relaxin signaling pathway Ko04742 Taste transduction
Ko00944 Flavone and flavonol biosynthesis Ko00450 Selenocompound metabolism Ko04621 NOD like receptor signaling pathway
Ko04110 Cell cycle Ko05219 Bladder cancer Ko04066 HF-1signaling pathway
Ko01240 Biosynthesis of co factor Ko05215 Prostrate cancer Ko05152 tuberculosis
Ko05321 Inflammatory bowel disease Ko04640 Hematopoietic cell lineage Ko00380 Tryotophan metabolism
Ko04934 Cushing syndrome Ko00232 Caffeine metabolism Ko04919 Thyroid hormone signaling pathway
Ko04657 IL-17 signaling pathway Ko04668 TNF signaling pathway Ko00260 Glycine,serine and threonine metabolism
Ko04658 Th1 and Th2 cell differentiation Ko04024 cAMP signaling pathway Ko00140 Steroid hormone biosynthesis
Ko04810 Regulation of actin cytoskeleton Ko04145 Phagosome
Ko04915 Estrogen signaling pathway
Ko04015 Rap1 signaling pathway Ko00910 Nitrogen metabolism ko04913 Ovarian steroidogenesis
Ko04013 MAPK signaling pathway-fly Ko04142 Lysosome
Ko05207 Chemical carcinogenesis-receptor activation
Ko03320 PRAP signaling pathway Ko05110 Vibrio cholera infection Ko04911 Insulin secretion
Ko04371 Apelin signaling pathway Ko04260 Cardiac muscle contraction Ko05208 Chemical carcinogenesis –reactive oxygen species
Ko00190 Oxidative phosphorylation Ko04261 Adrenergic signaling in cardiomyocytes Ko01522 Endrocrine resistance
Ko00071 Fatty acid degradation Ko00100 Steroid biosynthesis Ko04512 ECM -receptor interaction
Ko00590 Arachidonic acid metabolism Ko00980 Metabolism of xenobiotics by cytochrome P450 Ko05205 Proteoglycans in cancer
Ko00073 Cutin,suberine and wax biosynthesis Ko00860 Porphyrin metabolism Ko05206 microRNAs in cancer
Ko00591 Linoleic acid metabolism Ko00982 Drug metabolism-cytochrome P450 Ko05203 Viral carcinogenesis
Ko00195 photosynthesis Ko00983 Drug metabolism –other enzymes Ko04114 Oocyte meiosis
Ko05120 Epithelial cell signaling in Helicobacter pylori infection Ko00363 Bisphenol degradation Ko05144 malaria
Ko04670 Leukocyte transendothelial migration Ko04613 Neutrophil extracellular trap formation Ko05143 African trypanosomiasis
Ko04150 mTOR signaling pathway Ko04217 necroptosis Ko05131 Shigellosis
Ko04151 PI3K-Akt signaling pathway Ko04976 Bile secreation Ko05132 Salmonella infection
Ko05418 Fluid shear stress and atherosclerosis Ko04614 Renin angiotensin system Ko04978 Mineral absorption
Ko04390 Hippo signaling pathway Ko04218 Cellular senescence Ko04971 Gastric acid secretion
Ko04391 Hippo signaling pathway-fly Ko04974 Protein digestion and absroption Ko04964 Proximal tubule bicarbonate reclamation
Ko05417 Lipid and atherosclerosis Ko04972 Pancreatic secretion Ko05415 Diabetic cardimyopathy
Reactome id Description Reactome id Description Reactome id Description
R-HSA-6805567 keratinization R-HSA-5576892 Phase 0 rapid depolarisation R-BTA-450513 Tristetraprolin binds and destabilizes mRNA
R-HSA-9020958 Interleukin-21signaling R-HSA-8984722 Interleukin-20 family signaling R-HSA-727802 Transport of nucleotide sugars
R-HSA-8957275 Post-translational protein phosphorylation R-HSA-425986 Sodium exchange R-BTA-111447 Activation of BAD and translocation to mitrochondria
R-HSA-5579016 Defective UGT1A4 causes hyperbilurubinemia R-HSA-5579002 Defective UGT1A1 causes hyperbilirubinemia R-HSA-381426 Regulation of insulin-like Growth Factor transport and uptake by insulin
R-HSA-1592389 Activation of matrix Metalloproteinases R-BTA-392517 Rap 1 signaling R-HSA-1614603 Cysteine formation from homocysteine
R-HSA-9027307 Biosynthesis of maresin-like SPMs R-HSA-3000178 ECM proteoglycans R-HSA-77387 Insulin receptor recycling
R-HSA-2022377 Metabolism of Angiotensinogen to Angiotensins R-HSA-8854691 Interleukin-20 family signaling R-HSA-1222556 ROS and RNS production in phagocytes
R-BTA-5628897 TP53 regulates metabolic genes R-HSA-5576886 Phase 4- resting membrane potential R-BTA-75035 Chk1/Chk2 mediatyed inactivation of Cyclin B:cdk1 complex
R-HSA-1475029 Reversible hydration of carbon dioxide R-BTA-5675221 Negative regulation of MAPK activation R-HSA-189493 Heme degredation
R-HSA-447043 Neurofascin interactions R-HSA-983712 Ion channel transport R-HSA-8950505 Gene and protein expression by JAK-STAT signaling after interleukin-12
R-HSA-1299308 Tandem of pore domain in a weak inwardly rectifying K+ channels(TWIK) R-BTA -5674135 MAP2K and MAPK activation R-HSA-211916 Vitamins
R-HSA-447041 CHL1 interactions R-HSA-418890 Role of second messengers in netrin-1 signaling R-HSA-2672351 Stimuli-sensing channels
R-HSA-9020933 Interleukin-23 signaling R-HSA-3295583 TRP channels Plant Reactom ID Description
R-HSA-1566948 Elastic-fibre formation R-HSA-9660826 Purinergic signaling in leishmaniasis infection R-AHA-1119523 Tetrahydrofolate biosynthesis II
R-HSA-1299316 TWIK-related acid –sensitive K+(TASK) R-HSA-1237044 Erythrocyte take up carbon dioxide and release oxygen R-ACH-1119415 Leucopelargonidin and leucocyanidin biosynthesis
R-HSA-6785807 Interleukin-4 and interleukin-13 signaling R-HSA-877300 Interferon gramma signaling R-ACH-1119322 Leucodelphinidin biosynthesis
R-HSA-425381 Bicarbonate transporters R-HSA-9754706 Atorvastatin ADME R-ACH-9609573 Tricin biosynthesis
R-BTA-5673000 RAF activation R-HSA-448706 Interleukin-1 processing R-AHA-1119477 Starch biosynthesis
R-BTA-450385 BRF1 binds and destabilizes mRNA R-HSA-2408508 Metabolism of ingested SeMet,Sec,MeSec into H2Se R-QLO-5367729 Strigolactone biosynthesis
R-HSA-9623433 NR1H2 and NR1H3 regulate gene expression to control bile acid homeostate R-SSC-75205 Dissolution of fibrin clot R-AHA-1119265 Tetra ghydrofolate biosynthesis I
R-HSA-983231 Factors involved in megakaryocyte development and platelet production R-HSA-5423646 Aflatoxin activation and detoxification R-AHA-1119465 Sucrose biosynthesis
R-HSA-2160916 Hyaluronan uptake and degredation R-HSA-917977 Transferrin endocytosis and recycling R-HSA-1234174 Cellular responses to hypoxia
R-HSA-9757110 Prednisone ADME R-HSA-9027307 Biosynthesis of maresin-like SPMs R-HSA-189451 Heme biosynthesis
R-HSA-6798695 Neutrophil degranulation R-HSA-2672351 Stimuli-sensing channels R-HSA-9717207 Sensory perception of sweet,bitter and umami taste
R-BTA-166208 mTORC1- mediated signaling R-HSA-211916 Vitamins
R-HSA-114608 Platelate degranulation
R-BTA-5625740
RHO GTPases activate PKNs R-HSA-1299344 TRESK R-HSA-5619072 Defective SLC35A2 causes congential disorder of glycosylation 2M
R-HSA-1299344 TWIK-related spinal cord K+ channel R-HSA-9639288 Amino acids regulate mTORC1 R-HSA-196791 Vitamin D metabolism
R-HSA-9639288 Amino acids regulate mTORC1 R-HSA-9635465 Suppression of apoptosis R-HSA-1234174 Cellular responses to hypoxia
R-HSA-9635465 Suppression of apoptosis R-HSA-1989781 PPARA activates gene expressions R-HSA-189451 Heme biosynthesis
R-HSA-1989781 PPARA activates gene expression R-HSA-447038 NrCAM interactions R-HSA-9717207 Sensory perception of sweet,bitter and umami taste
R-HSA-447038 NrCAM interactions R-BTA-170968 Frs2-mediated activation R-BTA-114608 Platelate degranulation
R-HSA-170968 Frs2-mediated activation R-HSA-202733 Cell surface interactions at the vascular wall R-HSA-5619072 Defective SLC35A2 causes congential disorder of glycosylation 2M
R-HSA-202733 Cell surface interactions at the vascular wall R-HSA-156588 glucuronidation R-HSA-6803157 Antimicrobial peptides
R-HSA-156588 glucuronidation R-BTA-2028269 Signaling by Hippo R-HSA-6807878 COPI-mediated anterograde transport
R-HSA-2028269 Signaling by Hippo R-HSA-6783783 Interleukin-10 signaling R-HSA-6809371 Formation of the cornifide envelope
R-HSA-6783783 Interleukin-10 signaling R-HSA-445095 Interaction between L1 and Ankyrins R-HSA-9753281 Paracetamol ADME
R-HSA-1592389 Activation of Matrix MEtalloproteinases R-HSA-9749641 Asprine ADME R-HSA-8936459 RUNX1 regulates genes involved in megakaryocyte differentiation
R-HSA-211981 xenobiotics R-HSA-5619050 Defective SLC4A1 causes hereditary spherocytosis type 4 R-HSA-1299503 TWIK related potassium channel
R-HSA-1247673 Erythrocytes take up oxygen and release carbon dioxide R-HSA-5619054 Defective SLC4A4 causes renal tubular acidosis,poximal R-HSA-6803157 Antimicrobial peptides
R-HSA-5579010 Defective CYP24A1 causes HCAI R-BTA-96144399 Regulation of localization of FOXO transcription factors
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated